StarTribune.com
testedit081809

Home | Opinion Exchange | Commentary

Medical schools and drug companies too cozy

Last update: August 18, 2009 - 3:19 PM

"Is Low T making you a shadow of your former self?" asks the website.

From the looks of the slump-shouldered men on the page, you could hardly conclude anything else. These guys need some love -- and a jar of synthetic testosterone called AndroGel might just be their ticket.

The website was developed by Solvay Pharmaceuticals as part of an aggressive marketing campaign for the drug that also included a series of medical journal articles touting the benefits of testosterone. Those articles were sponsored by the University of Wisconsin School of Medicine and Public Health; Solvay paid about $1 million over a three-year period to fund them.

Doctors could read the articles and receive credit for continuing medical education -- and, Solvay hoped, write more prescriptions for AndroGel. UW received about $115,000 directly, according to a report by the Journal Sentinel's John Fauber, who uncovered the UW connection.

The problem? There is a lack of scientific evidence that men over the age of 45 benefit from taking testosterone. In fact, there are concerns that it might increase the risk of prostate cancer and cardiovascular disease.

The UW connection with Solvay is the latest example of the cozy relationships that have blossomed between medical schools and pharmaceutical companies. It's time for a divorce: Industry funding of continuing medical education should be phased out to avoid conflicts, and Congress should require full disclosure of all industry payments for continuing medical education.

The University of Wisconsin's good name has been tarnished by this money-grubbing enabling of a drug company's marketing campaign. In recent months, the school has taken steps to establish tougher conflict-of-interest rules. But UW hasn't moved to limit continuing medical education payments from industry, which may be an even larger risk to its reputation.

Recent Commentary stories

Google roundup: Hear, hear, for standing up against evil - August 18, 2009
Google roundup: Hear, hear, for standing up against evil - Google may not win its fight against the Chinese government, but bless it for trying. More

Comment on this story   |   Read all 1 comments   |  Hide reader comments

Subscribe

About Opinion Exchange

Opinion Exchange is produced by the Editorial Department, which is dedicated to hosting the discussion on a range of issues of interest to Star Tribune readers online and in print. In its new format, it's our hope that Opinion Exhange will create a more dynamic dialogue between Star Tribune readers and the Editorial Board. Many individual posts will be written and signed by members of the Editorial Board and will reflect their own opinions. Daily editorials will continue to represent the institutional voice of the newspaper and be researched and written by the Editorial Department, which is independent of the newsroom.

Subscribe to RSS|Learn more about RSS

Follow Opinion Exchange on Twitter Do you use Twitter? Follow Opinion Exchange.

StarTribune.com: Steals + Deals & Classifieds

Find A Job

Open positions!

A new career awaits. Look through thousands of listings to find your new job. Start now!
FYI Offers e-mails

Save Money With E-mail Offers

Sign up to receive FYI Offers e-mail containing specials from local businesses.

Win tickets to see Wild Beasts with Still Life Still at 7th Street Entry.

Vita.mn presents Wild Beasts with Still Life Still at 7th Street Entry on Feb. 17.

See all contests